NM_002582.4(PARN):c.1842G>A (p.Met614Ile) AND multiple conditions

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jul 10, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000806078.8

Allele description [Variation Report for NM_002582.4(PARN):c.1842G>A (p.Met614Ile)]

NM_002582.4(PARN):c.1842G>A (p.Met614Ile)

Gene:

PARN:poly(A)-specific ribonuclease [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

16p13.12

Genomic location:

Preferred name:

NM_002582.4(PARN):c.1842G>A (p.Met614Ile)

HGVS:

NC_000016.10:g.14446910C>T
NG_042871.1:g.188362G>A
NM_001134477.3:c.1659G>A
NM_001242992.2:c.1704G>A
NM_002582.4:c.1842G>AMANE SELECT
NP_001127949.1:p.Met553Ile
NP_001229921.1:p.Met568Ile
NP_002573.1:p.Met614Ile
LRG_1286t1:c.1842G>A
LRG_1286:g.188362G>A
LRG_1286p1:p.Met614Ile
NC_000016.9:g.14540767C>T
NM_002582.3:c.1842G>A

Protein change:

M553I

Links:

dbSNP: rs913617123

NCBI 1000 Genomes Browser:

rs913617123

Molecular consequence:

NM_001134477.3:c.1659G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001242992.2:c.1704G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_002582.4:c.1842G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Dyskeratosis congenita, autosomal recessive 6 (DKCB6)
Identifiers:: MONDO: MONDO:0014600; MedGen: C4225356; OMIM: 616353

Name:: Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4
Synonyms:: PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 4
Identifiers:: MONDO: MONDO:0014612; MedGen: C4225347; Orphanet: 2032; OMIM: 616371

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000946059	Invitae	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Jul 10, 2023)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000946059

Invitae

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Jul 10, 2023)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Invitae, SCV000946059.6

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant¬†is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 650846). This variant has not been reported in the literature in individuals affected with PARN-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 614 of the PARN protein (p.Met614Ile).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Mar 5, 2024

ClinVar

Relating variation to medicine